Press Releases

Press Releases

    Date Title View
    09/16/21
    Summary ToggleHorizon Therapeutics plc Named One of the 2021 Best Workplaces for Women™ by Fortune and Great Place to Work®
    PDF Version
    09/07/21
    Summary ToggleHorizon Therapeutics plc Initiates Randomized Controlled Clinical Trial Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Chronic (Inactive) Thyroid Eye Disease (TED)
    PDF Version
    09/01/21
    Summary ToggleHorizon Therapeutics plc Named One of PEOPLE’s 100 Companies That Care®
    PDF Version
    08/23/21
    Summary ToggleHorizon Therapeutics plc to Participate in Upcoming Conferences
    PDF Version
    08/04/21
    Summary ToggleHorizon Therapeutics plc Reports Record Second-Quarter 2021 Financial Results; Increasing Full-Year 2021 Net Sales and Adjusted EBITDA Guidance
    07/16/21
    Summary ToggleFortune Names Horizon Therapeutics One of the 2021 Best Workplaces for Millennials™
    PDF Version
    07/08/21
    Summary ToggleHorizon Therapeutics plc to Release Second-Quarter 2021 Financial Results and Host Webcast on Aug. 4, 2021
    PDF Version
    06/30/21
    Summary ToggleHorizon Therapeutics plc to Host Virtual R&D Day on Sept. 29, 2021
    PDF Version
    06/29/21
    Summary ToggleHorizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating HZN-7734 for the Treatment of Systemic Lupus Erythematosus
    PDF Version
    06/28/21
    Summary ToggleGail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease
    PDF Version
    Displaying 1 - 10 of 595 results